Search

Your search keyword '"Asthma -- Care and treatment"' showing total 3,561 results
Start Over Descriptor "Asthma -- Care and treatment"
3,561 results on '"Asthma -- Care and treatment"'

101. AAFA Applauds Senate Investigation into Pricing of Asthma Inhalers

Subjects
Pricing -- Political aspects -- Investigations, Drugs -- Investigations -- Political aspects, Asthma -- Care and treatment, Inhalers -- Investigations -- Political aspects, Company legal issue, Product price, Business, international, Law, Asthma and Allergy Foundation of America -- Investigations -- Political activity
Abstract

(GlobeNewswire) - The Asthma and Allergy Foundation of America (AAFA) today applauded the announcement of a U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) investigation into the high [...]

Published
2024

102. Opinion: Trump wants to replace Obamacare with something 'much better.' Voters would be wise to be skeptical

Subjects
Emergency medical services, Medical law, Medically uninsured persons, Asthma -- Care and treatment, General interest, News, opinion and commentary, Patient Protection and Affordable Care Act
Abstract

Byline: Opinion by Rob Davidson (CNN) -- (CNN) — Editor's note: Rob Davidson is an emergency physician in Michigan and executive director of the Committee to Protect Health Care, an [...]

Published
2024

103. 17 RESPIRATORY DISORDERE

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Corticosteroids
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 GlaxoSmithKline Rx Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2020

104. 17. RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Corticosteroids
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2020

105. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2020

106. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Respiratory system agents, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases, Diseases
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 GlaxoSmithKline Rx Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also:ADVAIRDISKUS5M 50 Rx Fluticasone [...]

Published
2020

108. 'A huge shock to the system': Doctors warn about asthma inhaler switch coming in January

Subjects
Generic drugs -- Marketing, Respiratory agents, Asthma -- Care and treatment, Company marketing practices, General interest, News, opinion and commentary
Abstract

Byline: Meg Tirrell, CNN (CNN) -- (CNN) — Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors [...]

Published
2023

109. Ethris Initiates First-in-Human Dosing in Phase 1 Study of ETH47 for the Treatment of Virus-Induced Asthma

Subjects
Antiviral agents -- Product development, Clinical trials -- Technology application -- Health aspects, Asthma -- Care and treatment, Technology application, Banking, finance and accounting industries, Business
Abstract

Phase 1 clinical trial will enroll 88 healthy volunteers in the United Kingdom ETH47 is a first-in-class, broadly protective antiviral candidate developed using Ethris' proprietary platform technologies for the treatment [...]

Published
2023

110. Connect Biopharma to Announce Top-Line Data from Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

Subjects
Biological products industry -- Product development, Asthma -- Care and treatment, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Connect Biopharma Holdings Limited (Nasdaq: CNTB) ('Connect Biopharma' or the 'Company'), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through [...]

Published
2023

111. Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

Subjects
Biological products industry -- Product development, Asthma -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, CA and TAICANG, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ('Connect Biopharma' or the 'Company'), a global clinical-stage biopharmaceutical company dedicated to [...]

Published
2023

112. Researcher's Work from IRCCS Ospedale Policlinico San Martino Focuses on Monoclonal Antibodies (Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab)

Subjects
Care and treatment, Reports, Monoclonal antibodies -- Reports, Immunotherapy -- Reports, Asthma -- Care and treatment
Abstract

2024 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New study results on monoclonal antibodies have been published. According to news reporting from Genoa, [...]

Published
2024

113. New Findings in Asthma Described from Imperial College London (Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison)

Subjects
AstraZeneca PLC, University of London. Imperial College of Science and Technology, Care and treatment, Analysis, Chronic diseases -- Care and treatment, Benralizumab -- Analysis, Patient compliance -- Analysis, Immunotherapy -- Analysis, Pharmaceutical industry -- Analysis, Asthma -- Care and treatment
Abstract

2024 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on asthma have been published. According to news reporting from London, United [...]

Published
2024

114. Findings from AstraZeneca Provides New Data about Asthma (Population Pharmacokinetic Modeling and Exposure-efficacy and Body Weight-response Analyses for Tezepelumab In Patients With Severe, Uncontrolled Asthma)

Subjects
AstraZeneca PLC -- Reports, Care and treatment, Models, Reports, Monoclonal antibodies -- Models -- Reports, Body weight -- Reports -- Models, Immunotherapy -- Models -- Reports, Pharmaceutical industry -- Reports -- Models, Asthma -- Care and treatment
Abstract

2024 MAY 15 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Lung Diseases and Conditions - Asthma. According to news reporting [...]

Published
2024

116. How to handle your cat's feline asthma

Subjects
Cats -- Methods, Asthma -- Care and treatment, Company business planning
Abstract

An expert has tips for you to help your cat breathe easy with feline asthma. Spring is often described as a time of renewal and beauty, with flowers blooming and [...]

Published
2024

118. University Indonesia Researchers Have Provided New Study Findings on Asthma (Effectiveness and Safety of Nebulized Magnesium as Last Line Treatment in Adults with Acute Asthma Attack: A Systematic Review and Meta-Analysis)

Subjects
Diseases, Care and treatment, Analysis, Reports, Safety and security measures, Asthma -- Care and treatment, Adults -- Reports -- Safety and security measures -- Analysis
Abstract

2024 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on asthma are presented in a new report. According to news [...]

Published
2024

119. Recent Findings in Asthma Described by Researchers from Genentech Inc. (Effectiveness of Omalizumab Across Different Dosing Regimens In Patients With Moderate-to-severe Allergic Asthma)

Subjects
Care and treatment, Reports, Asthma -- Care and treatment, Omalizumab -- Reports, Biological products industry -- Reports, Immunoglobulin E -- Reports
Abstract

2024 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators publish new report on Lung Diseases and Conditions - Asthma. According to news [...]

Published
2024

120. Department of Anesthesiology Researchers Detail Findings in Bioinformatics (Bioinformatics analysis revealed underlying molecular mechanisms associated with asthma severity and identified GABAergic related pathway as a potential therapy for ...)

Subjects
Care and treatment, Reports, GABA -- Reports, Computational biology -- Reports, Asthma -- Care and treatment
Abstract

2024 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Fresh data on bioinformatics are presented in a new report. According to news reporting [...]

Published
2024

121. Recent Studies from University of La Frontera Add New Data to Chronic Obstructive Pulmonary Disease (Retrospective Analysis of the Ventilatory Workload Kinetic Index during Stability and Crisis in Patients with Asthma and COPD in a Monitored ...)

Subjects
Care and treatment, Analysis, Medical research -- Analysis, Asthma -- Care and treatment, Medicine, Experimental -- Analysis
Abstract

2024 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on chronic obstructive pulmonary disease. According to news originating [...]

Published
2024

122. New Asthma Study Results from Ningbo University Described (Treating Asthma Patients With Probiotics: a Systematic Review and Meta-analysis)

Subjects
Care and treatment, Analysis, Respiratory system agents -- Analysis, Probiotics -- Analysis, Asthma -- Care and treatment, Respiratory agents -- Analysis
Abstract

2024 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Lung Diseases and Conditions - Asthma is the subject of [...]

Published
2024

123. Best practices in managing asthma patients

Author

Rosenfeld, Jordan

Subjects
Practice, Care and treatment, Methods, Physicians -- Practice, Patient compliance -- Methods, Asthma -- Care and treatment
Abstract

Asthma not only impairs the breathing and quality of life of more than 25 million people who live with it, it poses an immense financial burden to the U.S. healthcare [...]

Published
2019

124. I Say IOS You Say AOS: Comparative Bias in Respiratory Impedance Measurements

Author

Kuo, Chris RuiWen, Jabbal, Sunny, and Lipworth, Brian

Subjects
Care and treatment, Analysis, Practice guidelines (Medicine) -- Analysis, Asthma -- Care and treatment
Abstract

Author(s): Chris RuiWen Kuo [sup.1] , Sunny Jabbal [sup.1] , Brian Lipworth [sup.1] Author Affiliations: (Aff1) 0000 0004 0397 2876, grid.8241.f, Scottish Centre for Respiratory Research, Ninewells Hospital and Medical [...], Background The forced oscillation technique (FOT) measures respiratory impedance during normal tidal breathing and requires minimal patient cooperation. Objective To compare IOS and AOS devices in patients with asthma and COPD. Methods We compared two different FOT devices, namely impulse oscillometry using a loudspeaker (IOS: Jaeger Masterscreen) and airwave oscillometry using a vibrating mesh (AOS: Thorasys Tremoflo) for pre- and post-bronchodilator measurements in 84 patients with asthma and COPD. Results The overall pattern of measurement bias was for higher resistance with IOS and higher reactance with AOS, this being the case in asthma and COPD separately. There were small but significantly higher values using IOS for resistance at 5 Hz (R5) and 20(19) Hz (R20(19)). In converse, values for reactance at 5 Hz (X5), reactance area (AX) and resonant frequency (Fres) were significantly higher using AOS but to a much larger extent. The difference in AX between devices was more pronounced in COPD than in asthma. Salbutamol reversibility as % change was greater in asthma than COPD patients with AX but not FEV1. Conclusion Our study showed evidence of better agreement for resistance than reactance when comparing IOS and AOS, perhaps inferring that AOS may be more sensitive at measuring reactance in patients with airflow obstruction.

Published
2019
Full Text
View/download PDF

125. Survey: 42% of PCPs not familiar with biologics for asthma

Author

Frellick, Marcia

Subjects
University of South Florida, Care and treatment, Asthma -- Care and treatment
Abstract

ANAHEIM, CALIF. -- Patients with uncontrolled asthma are seen more often by primary care providers (PCPs) than by allergists, but a survey has found that 42% of PCPs are unfamiliar [...]

Published
2024

126. Survey: 42% of PCPs not familiar with biologics for asthma

Author

Frellick, Marcia

Subjects
University of South Florida, Care and treatment, Asthma -- Care and treatment
Abstract

ANAHEIM, CALIF.--Patients with uncontrolled asthma are seen more often by primary care providers (PCPs) than by allergists, but a survey has found that 42% of PCPs are unfamiliar with the [...]

Published
2023

127. Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity

Author

Goldberg, Ron

Subjects
Care and treatment, Reports, Patient compliance -- Reports, Medical research -- Reports, Asthma -- Care and treatment, Medicine, Experimental -- Reports
Abstract

Risk for exacerbations exists among patients with asthma regardless of control level, treatment adherence, or disease severity, according to study findings presented at the American College of Allergy, Asthma & [...]

Published
2022
Full Text
View/download PDF

129. Investigators from University of Vermont Have Reported New Data on Asthma (An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma)

Subjects
Care and treatment, Methods, Obesity -- Care and treatment, Telemedicine -- Methods, Asthma -- Care and treatment, Weight loss -- Methods
Abstract

2022 OCT 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Lung Diseases and Conditions - Asthma. According [...]

Published
2022

130. AstraZeneca's Tezspire receives European approval to treat severe asthma

Subjects
AstraZeneca PLC, European Union, Tezspire (Medication), Care and treatment, Clinical trials, Pharmaceutical industry, Drug approval, Asthma -- Care and treatment
Abstract

AstraZeneca's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on maintenance treatment in patients 12 years and older with severe asthma who are inadequately controlled with [...]

Published
2022

131. Teva: Patient who used ProAir Digihaler boost weekly number of SABA-free days

Subjects
Teva Pharmaceutical Industries Ltd. -- Reports, Pharmaceutical industry -- Reports, Asthma -- Care and treatment, Business, News, opinion and commentary, ProAir Digihaler (Medication) -- Reports
Abstract

Teva Pharmaceuticals announced that full results from the CONNECT1 study evaluating the ProAir Digihaler , albuterol sulfate, Inhalation Powder and the Digihaler System in the management of asthma patients compared [...]

Published
2022

133. Treating Severe Eosinophilic Asthma: Mepolizumab vs Benralizumab

Author

Schad, Virginia A.

Subjects
Care and treatment, Benralizumab, Asthma -- Care and treatment
Abstract

Mepolizumab and benralizumab are highly effective for patients with severe eosinophilic asthma, according to a study presented at the American Thoracic Society (ATS) International Conference 2022, held in San Francisco, [...]

Published
2022

134. How Does Omalizumab Affect Antitussive Use in Patients With Allergic Asthma?

Author

Schad, Virginia A.

Subjects
Care and treatment, Omalizumab, Asthma -- Care and treatment
Abstract

Omalizumab may decrease antitussive use in patients with allergic asthma, according to a study presented at the American Thoracic Society (ATS) International Conference 2022 held in San Francisco, CA, May [...]

Published
2022

135. Kyung Hee University Researchers Target Asthma (Rosa laevigata Attenuates Allergic Asthma Exacerbated by Water-Soluble PM by Downregulating the MAPK Pathway)

Subjects
Care and treatment, Usage, Health aspects, Roses -- Usage -- Health aspects, Asthma -- Care and treatment, Particulate matter -- Health aspects, Signaling peptides and proteins -- Health aspects
Abstract

2022 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on asthma. According to news originating from Seoul, [...]

Published
2022

136. Researchers at First Affiliated Hospital of Nanjing Medical University Target Asthma (Chloroquine Attenuates Asthma Development by Restoring Airway Smooth Muscle Cell Phenotype Via the ROS-AKT Pathway)

Subjects
Testing, Care and treatment, Genetic aspects, Health aspects, Phenotypes -- Health aspects, Chloroquine -- Testing, Smooth muscle -- Genetic aspects -- Health aspects, Airway -- Genetic aspects -- Health aspects, Asthma -- Care and treatment, Phenotype -- Health aspects, Airway (Medicine) -- Genetic aspects -- Health aspects
Abstract

2022 JUN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on asthma is the subject of a new report. According [...]

Published
2022

137. What you need to know about the albuterol shortages

Author

Rajab, Fazila

Subjects
Management, Care and treatment, Supply and demand, Forecasts and trends, Product shortage, Company business management, Market trend/market analysis, Shortages -- Forecasts and trends -- Management, Child health -- Care and treatment, Albuterol -- Supply and demand, Asthma -- Care and treatment, Children -- Health aspects
Abstract

Manufacturers, hospitals, and clinicians are working quickly to address the shortages of this crucial inhalation solution. Pediatric hospitals across the United States are facing a shortage of albuterol sulfate inhalation [...]

Published
2023

138. Inspiration from unexpected places: How pharmaceutical companies can learn from advances in nicotine delivery

Subjects
Homeopathy -- Materia medica and therapeutics, Product development, Therapeutics -- Innovations, Tiotropium -- Innovations, Asthma -- Care and treatment, Time to market, Business, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Business, international
Abstract

Inhalation therapy is the foundation of many treatments for respiratory diseases, such as COPD and asthma, which affect hundreds of millions of people worldwide. However, there is a need for [...]

Published
2023

140. OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand Real-World Evidence in Respiratory and ENT

Subjects
Medical research, Medicine, Experimental, Chronic diseases -- Care and treatment, Asthma -- Care and treatment, Business, Business, international
Abstract

New datasets deliver insights into treatment effectiveness, patient subtypes, and patient outcomes for accelerating research and improving decision making BOSTON -- OM1, a leading real-world data, AI, and technology company [...]

Published
2023

141. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Respiratory system agents, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases, Diseases
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 GlaxoSmithKline Rx Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2020

142. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Respiratory system agents, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases
Abstract

17A Asthma/COPD > ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS [...]

Published
2019

143. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Antiasthmatic agents, Respiratory system agents, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Zileuton, Fluticasone, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases, Omalizumab
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2019

144. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Respiratory system agents, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases
Abstract

17A Asthma/COPD * ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS [...]

Published
2019

145. 17 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Respiratory system agents, Bronchial spasm, Corticosteroid drugs, Respiratory tract diseases
Abstract

17A Asthma/COPD > ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS [...]

Published
2019

146. 17 RESPIRATORY DISORDERS

Subjects
AstraZeneca PLC, Merck & Company Inc., Advair Diskus (Medication), Mucinex (Medication), Care and treatment, Pharmaceutical industry, Fluticasone, Ciclesonide, Vilanterol, Glucocorticoids, Atazanavir, Asthma -- Care and treatment, Respiratory tract diseases, Corticosteroid drugs, Bronchial spasm, Respiratory system agents, Steroids (Organic compounds)
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2019

147. Managing asthma: Improve outcomes, boost payment

Author

Eramo, Lisa A.

Subjects
Care and treatment, Practice, Analysis, Asthma -- Care and treatment, Physicians -- Practice, Health care costs -- Analysis, Outcome and process assessment (Medical care) -- Analysis, Medicare Access and CHIP Reauthorization Act of 2015
Abstract

By focusing on asthma management, physicians not only improve patient outcomes and reduce healthcare spending, they also earn more money. Asthma is a condition targeted under the Medicare Access and [...]

Published
2018

148. 17 RESPIRATORY DISORDERS

Subjects
AstraZeneca PLC, Merck & Company Inc., Advair Diskus (Medication), Mucinex (Medication), Care and treatment, Pharmaceutical industry, Fluticasone, Ciclesonide, Vilanterol, Glucocorticoids, Atazanavir, Asthma -- Care and treatment, Respiratory tract diseases, Corticosteroid drugs, Bronchial spasm, Respiratory system agents, Steroids (Organic compounds)
Abstract

17A Asthma/COPD > ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS [...]

Published
2019

149. The Use of Intravenous Magnesium and Alpha Lipoic Acid: SHOULD MORE CHIROPRACTORS PERFORM INTRAVENOUS INFUSIONS AS ADJUNCT THERAPY?

Author

Isaza, Adrian

Subjects
Practice, Care and treatment, Usage, Surveys, General practitioners -- Practice, Alternative medicine -- Usage -- Surveys, Asthma -- Care and treatment, Magnesium products -- Usage
Abstract

Two surveys were conducted on 199 complementary and alternative medicine practitioners for the years 2006 and 2008. The surveys showed that out of 199 practitioners, 172 administered intravenous vitamin C [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results